Coherus Biosciences | CHRS - Stock





Stock Veränderung Datum
AbbVie USD 5.05B 98M 2026-03
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Akebia Therapeutics USD 13M 2.61M 2026-03
ALKERMES USD 336.7M 140.08M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amarin USD 183.58M 12.32M 2026-03
Amgen USD 6.19B 39M 2026-03
Baxter International USD 2.32B 84M 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 14.53B 785M 2026-03
Fujifilm JPY 600.12B 1.55B 2025-09
Gilead Sciences USD 1.91B 140M 2026-03
Merck USD 6.48B 179M 2026-03
Myriad Genetics USD 27.9M 2.7M 2026-03
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Pfizer USD 10.67B 13M 2026-03
PTC Therapeutics USD 75.57M 4.08M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sarepta Therapeutics USD 1B 86.37M 2026-03
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03
Zoetis USD 2.55B 120M 2026-03